Mark R. Szewczak

820 total citations
13 papers, 662 citations indexed

About

Mark R. Szewczak is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark R. Szewczak has authored 13 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark R. Szewczak's work include Neuroscience and Neuropharmacology Research (3 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). Mark R. Szewczak is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). Mark R. Szewczak collaborates with scholars based in United States, France and Canada. Mark R. Szewczak's co-authors include Sharmonay Fielding, Michael L. Cornfeldt, Roy Corbett, Jeffrey C. Wilker, Lal H, W J Novick, Mary Hynes, Craig P. Smith, Robert W. Dunn and Gina M. Bores and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Mark R. Szewczak

13 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Szewczak United States	10	320	267	135	130	129	13	662
B Nickel Germany	18	428 1.3×	385 1.4×	161 1.2×	174 1.3×	78 0.6×	42	952
Leroy R. Reid United States	15	565 1.8×	337 1.3×	78 0.6×	123 0.9×	258 2.0×	18	1.0k
Marshall B. Wallach United States	15	269 0.8×	177 0.7×	134 1.0×	83 0.6×	176 1.4×	27	697
Deborah K. Hyslop United States	12	515 1.6×	324 1.2×	93 0.7×	61 0.5×	142 1.1×	19	900
J. Bruinvels Netherlands	19	416 1.3×	326 1.2×	49 0.4×	131 1.0×	112 0.9×	54	845
Stephen M. Sorensen United States	14	487 1.5×	278 1.0×	176 1.3×	60 0.5×	67 0.5×	19	816
Irena Romańska Poland	18	558 1.7×	268 1.0×	90 0.7×	151 1.2×	147 1.1×	52	927
William J. Giardina United States	15	324 1.0×	354 1.3×	86 0.6×	61 0.5×	130 1.0×	26	721
Helen Lamb United Kingdom	9	346 1.1×	298 1.1×	48 0.4×	127 1.0×	92 0.7×	9	574
Christine Ennis United Kingdom	14	541 1.7×	349 1.3×	92 0.7×	92 0.7×	60 0.5×	36	838

Countries citing papers authored by Mark R. Szewczak

Since Specialization

Citations

This map shows the geographic impact of Mark R. Szewczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Szewczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Szewczak more than expected).

Fields of papers citing papers by Mark R. Szewczak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Szewczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Szewczak. The network helps show where Mark R. Szewczak may publish in the future.

Co-authorship network of co-authors of Mark R. Szewczak

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Szewczak. A scholar is included among the top collaborators of Mark R. Szewczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Szewczak. Mark R. Szewczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Smith, Craig P., Roy Corbett, Roger D. Porsolt, et al.. (1997). Anti‐Obsessional and Antidepressant Profile of Besipirdine. CNS Drug Reviews. 3(1). 1–23. 9 indexed citations

Corbett, Roy, Lyn R. Griffiths, James E. Shipley, et al.. (1997). Iloperidone: Preclinical Profile and Early Clinical Evaluation. CNS Drug Reviews. 3(2). 120–147. 23 indexed citations

Burgher, Kendra L., Harold B. Hartman, Lisa L. Kerman, et al.. (1996). Structure−Activity Relationships of a Series of Novel (Piperazinylbutyl)thiazolidinone Antipsychotic Agents Related to 3-[4-[4-(6-Fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5-trimethyl-4- thiazolidinone Maleate. Journal of Medicinal Chemistry. 39(20). 4044–4057. 29 indexed citations

Smith, Craig P., Roy Corbett, Mark R. Szewczak, et al.. (1996). Besipirdine (HP 749) reduces schedule-induced polydipsia in rats. Brain Research Bulletin. 41(2). 125–130. 15 indexed citations

Strupczewski, Joseph T., Edward J. Glamkowski, Paul Conway, et al.. (1995). 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873). Journal of Medicinal Chemistry. 38(7). 1119–1131. 66 indexed citations

Szewczak, Mark R., Roy Corbett, Douglas K. Rush, et al.. (1995). The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1404–1413. 43 indexed citations

Smith, Craig P., et al.. (1993). Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology. 112(2-3). 195–198. 101 indexed citations

SHUTSKE, G. M., Michael L. Cornfeldt, Mark R. Szewczak, et al.. (1989). 9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeutics. Journal of Medicinal Chemistry. 32(8). 1805–1813. 84 indexed citations

SHUTSKE, G. M., Michael L. Cornfeldt, Mark R. Szewczak, et al.. (1988). (.+-.)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity. Journal of Medicinal Chemistry. 31(7). 1278–1279. 48 indexed citations

10.

Szewczak, Mark R., Michael L. Cornfeldt, Robert W. Dunn, et al.. (1987). Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profile. Drug Development Research. 11(3-4). 157–168. 9 indexed citations

11.

Szewczak, Mark R., et al.. (1986). Opiate-induced turning in rats after injection into the ventral tegmental area. Pharmacology Biochemistry and Behavior. 25(5). 959–965. 4 indexed citations

12.

Fielding, Sharmonay & Mark R. Szewczak. (1984). Pharmacology of nomifensine: a review of animal studies.. PubMed. 45(4 Pt 2). 12–20. 29 indexed citations

13.

Fielding, Sharmonay, Jeffrey C. Wilker, Mary Hynes, et al.. (1978). A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.. Journal of Pharmacology and Experimental Therapeutics. 207(3). 899–905. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact